Virtual Library
Start Your Search
O. Glogowska
Author of
-
+
P1.08 - Poster Session with Presenters Present (ID 460)
- Event: WCLC 2016
- Type: Poster Presenters Present
- Track: Surgery
- Presentations: 1
- Moderators:
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.08-007 - The Significant Improvement of Lung Function after Preoperative Rehabilitation in Patients with Thoracic Tumors and Abnormal Spirometry (ID 3902)
14:30 - 14:30 | Author(s): O. Glogowska
- Abstract
Background:
The evaluation of degree of improvement of exercise tolerance and rest lung function parameters after preoperative pulmonary rehabilitation in patients with thoracic tumors and baseline borderline abnormal spirometry results.
Methods:
Clinical inclusion criteria were: diagnosis of thoracic tumors and reduced values of FEV1 and FVC predicting postoperative complications. We observed 29 patients (16 women, 13 men) in mean age of 68 (range 57-68) years. Spirometry, six minute walking test distance (6MWT) and maximum metabolic equivalent during exercise on treadmill (MET) were chosen for evaluation of lung function and physical performance during rehabilitation. The tests were performed twice during screening phase to eliminate the factors of learning, and were repeated after first and second week of rehabilitation. Pulmonary rehabilitation included two weeks of training on the treadmill with individually selected speed, physiotherapy exercises and breathing training with using of Triflo.
Results:
The significant differences were observed after pulmonary rehabilitation: 1). FEV 1 (L): 1.41 vs 1.58 (p=0.000027) 2). FEV1 (%N): 60.49 vs 71.49 (p=0.000021) 3). FVC (L): 2.34 vs 2.64 (p=0. 000520) 4). FVC (%N): 79 vs 95 (p=0.000269) 5). 6MWT Distance (m): 350 vs 400 (p=0.000007) 6). MET: 2.66 vs 2.905 (p=0.000007)
Conclusion:
A two-week pulmonary rehabilitation leads to significantly improvement of lung function and physical performance in patients with thoracic tumors and borderline abnormal spirometry results which may provide significantly better outcome of patients in short- and longtime follow-up.